Program Overview
ON-DEMAND THRU SEPTEMBER 23, 2023
Chronic kidney disease (CKD) has an estimated global prevalence of
between 11 to 13%. Over 2 million people worldwide suffer from end-stage renal
disease (ESRD) requiring dialysis or kidney transplantation, and is associated
with a significant medical and economic burden. Genetic kidney disease affects
nearly 10% of adults with CKD, and up to 70% of children with early-onset
kidney disease. In the recent years, the diagnosis and management of patients
affected by genetic kidney disease has rapidly evolved. Genomics has allowed
better understanding of disease pathogenesis, providing prognostic information and
facilitating development of targeted treatments for patients with genetic
kidney disorders. However, the dissemination of this critical knowledge is not
widespread. There is a real need to educate providers in the use of genetic
testing in routine clinical practice.
Learning Objectives
Discuss advances in the diagnosis of genetic disorders in the
kidney clinic.
Explore case-based examples of how a genetic diagnosis can help management
of kidney patients.
Target Audience
Health Care Providers including: Adult specialty practitioners,
pediatricians, primary care physicians; geneticists; physician assistants,
nurse practitioners, nurses, and pharmacists; and any other HCPs with an
interest in or who may clinically encounter patients.
Accreditation Statement
In
support of improving patient care, this activity has been planned and
implemented by Amedco LLC and Columbia University. Amedco LLC is jointly
accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education
(ACPE), and the American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.
Physicians (ACCME) Credit Designation Statement
Amedco LLC designates this live virtual activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Genetic Counselors
Learners must self-submit for Category 2 credits to the National Society
of Genetic Counselors (NSGC).
For questions, contact certificate@amedcoemail.com.
American Board of Internal Medicine (ABIM) MOC Credit
Successful
completion of this CME activity, which includes participation in the
evaluation component, enables the participant to earn up to x.x Medical
Knowledge MOC points in the American Board of Internal Medicine's
(ABIM) Maintenance of Certification (MOC) program. It is the CME
activity provider's responsibility to submit participant completion
information to ACCME for the purpose of granting ABIM MOC credit. You
must request your certificate within 30 days of the activity to meet the
deadline for submission to PARS.